Table 1 Demographic characteristics and baseline characteristics of study disease (Pooled ITT Population)
Parameter | BCD-021 (N = 205) n (%) | Reference bevacizumab (N = 136) n (%) |
|---|---|---|
Race Asian | 138 (67.32) | 71 (52.21) |
Black | 0 | 1 (0.74) |
White | 67 (32.68) | 64 (47.06) |
Sex | ||
 Male | 142 (69.27) | 88 (64.71) |
 Female | 63 (30.73) | 48 (35.29) |
Childbearing potential (Female) | ||
 Yes | 12 (5.85) | 8 (5.88) |
ECOG score | ||
0 | 41 (20.00) | 25 (18.38) |
1 | 154 (75.12) | 101 (74.26) |
2 | 10 (4.88) | 10 (7.35) |
Allergy | ||
 Yes | 2 (0.98) | 5 (3.68) |
Stage | ||
 III | 5 (2.44) | 8 (5.88) |
 IIIB | 23 (11.22) | 16 (11.76) |
 IV | 177 (86.34) | 112 (82.35) |
Histological type | ||
 Adenocarcinoma | 202 (98.54) | 134 (98.53) |
 Bronchoalveolar | 3 (1.46) | 1 (0.74) |
 Large cell | 0 | 1 (0.74) |